WuXi AppTec opens second NJ-based site following ongoing expansion efforts

By Melissa Fassbender contact

- Last updated on GMT

New Jersey State Senator Linda Greenstein attended the grand opening. (Image: WuXi AppTec)
New Jersey State Senator Linda Greenstein attended the grand opening. (Image: WuXi AppTec)
WuXi AppTec is converting its Plainsboro, NJ lab into a fully GLP-regulated bioanalytics facility after opening a new site in Cranbury which doubles the company’s total operation space to more than 115,000 square feet.

“The company’s strength in bioanalytical and DMPK services has been heavily driven by increasing customer demand for regulatory-compliant solutions over the past two to three years,” ​said Dr. Jason Liu, SVP of WuXi AppTec, COO of the Laboratory Testing Division.

“The site expansion bolsters WuXi’s Laboratory Testing Division in these services and establishes New Jersey site as a center of excellence in providing IND and NDA enabling services,​” he told us.

When fully configured, Liu said the new facility add 55,000 square feet of laboratory space to WuXi AppTec’s Laboratory Testing Division (LTD) as well as more than 200 new jobs.

“This addition expands upon our established Plainsboro facility, offering testing services to pharmaceutical and biotech companies,”​ he explained.

Additionally, “through the expansion efforts,”​ Liu said the company will be converting its current Plainsboro laboratory into a fully good laboratory practice (GLP) regulated bioanalytics facility with double the space.

WuXi’s Laboratory Testing Division provides in vivo​ and in vitro​ assays from early screening to clinical sample analysis, as well as medical device testing from development to product lifecycle management.

Related news

Show more

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q² Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Related suppliers

Follow us


View more